We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$23.3B
AUM Growth
-$265M
Cap. Flow
-$917M
Cap. Flow %
-3.93%
Top 10 Hldgs %
47.97%
Holding
197
New
23
Increased
32
Reduced
40
Closed
30

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$386M
2
AON icon
Aon
AON
+$368M
3
CTLT
CATALENT, INC.
CTLT
+$282M
4
CRM icon
Salesforce
CRM
+$266M
5
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$184M

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$924M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$262M
3
CSGP icon
CoStar Group
CSGP
+$251M
4
INSP icon
Inspire Medical Systems
INSP
+$135M
5
WAB icon
Wabtec
WAB
+$123M

Sector Composition

Rank Sector Weight
1 Healthcare 29.33%
2 Technology 12.47%
3 Financials 9.64%
4 Industrials 5.44%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
51
Amgen
AMGN
$222B
$72.5M 0.31%
+232,000
New +$68.2M
GERN icon
52
Geron
GERN
$949M
$71.4M 0.31%
16,837,000
+9,342,000
+125% +$36.4M
BEKE icon
53
KE Holdings
BEKE
$18.8B
$67.1M 0.29%
4,740,833
– –
X
54
DELISTED
US Steel
X
$64.6M 0.28%
1,710,000
-1,480,000
-46% -$56.5M
ICLR icon
55
Icon
ICLR
$12.7B
$55.9M 0.24%
178,200
-1,500
-0.8% -$470K
COR icon
56
Cencora
COR
$61.2B
$54.7M 0.23%
242,800
-91,200
-27% -$21.1M
CERE
57
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$48.7M 0.21%
1,190,000
+127,000
+12% +$5.29M
SIMO icon
58
Silicon Motion
SIMO
$8.68B
$46M 0.2%
567,534
-287,915
-34% -$22.5M
UTHR icon
59
United Therapeutics
UTHR
$23.1B
$45.6M 0.2%
143,000
+33,000
+30% +$8.73M
INSM icon
60
Insmed
INSM
$28.6B
$38.1M 0.16%
+568,000
New +$22M
PGNY icon
61
Progyny
PGNY
$2.2B
$37.4M 0.16%
1,308,500
+715,900
+121% +$21.6M
FLUT icon
62
Flutter Entertainment
FLUT
$16.4B
$36.6M 0.16%
+200,800
New +$38.6M
CRSP icon
63
CRISPR Therapeutics
CRSP
$5.17B
$28.6M 0.12%
+530,000
New +$30.7M
ENTA icon
64
Enanta Pharmaceuticals
ENTA
$400M
$27.2M 0.12%
2,095,000
– –
CHX
65
DELISTED
ChampionX
CHX
$26.1M 0.11%
+785,000
New +$26.8M
AXNX
66
DELISTED
Axonics, Inc. Common Stock
AXNX
$24.9M 0.11%
370,000
+145,000
+64% +$9.77M
LQDA icon
67
Liquidia Corp
LQDA
$8.02B
$24.7M 0.11%
2,055,000
– –
CRNX icon
68
Crinetics Pharmaceuticals
CRNX
$8.92B
$22.3M 0.1%
497,000
+492,000
+9,840% +$22.7M
PCVX icon
69
Vaxcyte
PCVX
$8.64B
$21.9M 0.09%
290,000
-87,400
-23% -$5.95M
SRPT icon
70
CALL
Sarepta Therapeutics
SRPT
$1.77B
$21.1M 0.09%
+133,300
New +$17.1M
DFS
71
DELISTED
Discover Financial Services
DFS
$20.9M 0.09%
160,000
– –
SVRA icon
72
Savara
SVRA
$1.19B
$18.4M 0.08%
4,560,000
+2,165,701
+90% +$9.64M
VYGR icon
73
Voyager Therapeutics
VYGR
$198M
$18.1M 0.08%
2,292,000
– –
CNTA
74
DELISTED
Centessa Pharmaceuticals
CNTA
$18M 0.08%
1,996,000
+1,625,000
+438% +$15.4M
SYRE icon
75
Spyre Therapeutics
SYRE
$9.25B
$15.7M 0.07%
666,000
+200,000
+43% +$6.75M
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Farallon Capital Management held 197 positions worth $23.3B, down 1.1% from $23.6B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Farallon Capital Management withdrew a net $917M in Q2 2024, closing 30 positions and reducing 40 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $924M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Walt Disney worth $356M.

  • Farallon Capital Management's largest Q2 2024 buy was Walt Disney: 3,582,168 shares worth $356M.
  • Farallon Capital Management added most to Aon in Q2 2024, an estimated $368M increase.
  • Farallon Capital Management's biggest Q2 2024 reduction was Alphabet (Google) Class C, cutting an estimated $262M.
  • Farallon Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $924M.
  • Farallon Capital Management's ten largest holdings make up 48% of its $23.3B portfolio in Q2 2024.
  • Farallon Capital Management opened 23 new positions and closed 30 in Q2 2024.
  • Farallon Capital Management's portfolio value fell 1.1% quarter-over-quarter to $23.3B.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.